In this cross-sectional study, cervical cancer remained a major public health issue in some US-Affiliated Pacific Islands, with the Republic of the Marshall Islands reporting the highest incidence rates. https://ja.ma/3TuR6fr
JAMA Oncology
图书期刊出版业
Chicago，Illinois 36,048 位关注者
A member of the JAMA Network, which includes JAMA, 11 specialty journals, and JAMA Network Open.
关于我们
JAMA Oncology is published online weekly, every Thursday, and in 12 print/online issues a year. The journal receives more than 6.4 million annual article views and downloads. Without any author fees, all research articles are made free access online 12 months after publication on the website. In addition, the online version is freely available or nearly so to institutions in developing countries through the World Health Organization's HINARI program. JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. The journal’s acceptance rate is 13%. The median time to first decision is 2 days, and 50 days with review. The Journal Impact Factor is 28.4, one of the highest ranking among oncology journals. All articles are published online first. Mary L. (Nora) Disis, MD, Director of the UW Institute of Translational Health Science and the Center for Translational Medicine in Women's Health, is the editor in chief.
- 网站
-
https://jamanetwork.com/journals/jamaoncology
JAMA Oncology的外部链接
- 所属行业
- 图书期刊出版业
- 规模
- 5,001-10,000 人
- 总部
- Chicago，Illinois
- 创立
- 2015
- 领域
- Oncology
动态
-
Single-center study shows significant racial disparity in colorectal cancer survival, particularly in metastatic cases. Socioeconomic factors are key, but molecular factors also play a role, underscoring the need for genetically informed treatment. https://ja.ma/3zsBsKG
-
-
Most viewed in the last 7 days from JAMA Oncology: What is the optimal approach for integrating ICIs in early-stage breast cancer? https://ja.ma/4egfytb
-
-
Next Generation Trial: phase 2 prospective validating paired-cohort trial finds 18F-PSMA-1007 PET/CT correctly identified the final pathological T-stage in 45% of men undergoing robotic prostatectomy compared to 28% w/ multiparametric MRI. https://ja.ma/4cVVz1P
-
-
Surveillance of high-risk individuals for pancreatic ductal adenocarcinoma using EUS or MRI led to a higher proportion of stage I cancers (31% vs 10%), longer 5-yr survival rate (50% vs 9%), and lower pancreatic cancer–specific mortality rate (43% vs 86%). https://ja.ma/3AZQoAD
-
-
Patients with stage I triple-negative breast cancer and high level of stromal tumor-infiltrating lymphocytes who did not receive neoadjuvant or adjuvant chemotherapy had excellent 10-year breast cancer–specific survival. https://ja.ma/3MSMYm1
-
-
Viewpoint evaluates the use of tumor tissue–modified HPV DNA in identifying minimal residual disease. https://ja.ma/3AUA7gb
-
-
This study reanalyzes epidermal growth factor receptor 2 (ERBB2) data from a previous study to characterize patient subgroups with ERBB2-low tumors. https://ja.ma/3XwqugE
-
-
Listen to an interview with Eileen M. O’Reilly author of "Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer," with Vivek Subbiah. https://ja.ma/3TfoerG
-
Most viewed in the last 7 days from JAMA Oncology: What is the optimal approach for integrating ICIs in early-stage breast cancer? https://ja.ma/4d0MvbH
-